论文部分内容阅读
1.临床记录患者,男性,48岁。肥胖,体重指数(BMI):30 kg/m2腰围(腹围):110 cm血压:150/105 mmHg甘油三酯:1.85 mmol/L总胆固醇:6.5 mmol/L空腹血糖:6.8 mmol/L诊断:高血压伴胰岛素抵抗,血脂异常,空腹血糖受损2.用药缬沙坦胶囊80 mg 1次/d马来酸罗格列酮片4 mg 1次/d3.分析(1)肥胖、体脂分布及高血压从临床及流行病学研究,肥胖常以体重指数[BMI,体重(kg)/身高(m)2]进行评估,按照世界卫生组织的定义:BMI≥25 kg/m2为超重,BMI≥30
1. Clinical records of patients, men, 48 years old. Body mass index (BMI): 30 kg / m2 Waist circumference: 110 cm Blood pressure: 150/105 mmHg Triglyceride: 1.85 mmol / L Total cholesterol: 6.5 mmol / L Fasting plasma glucose: 6.8 mmol / L Diagnosis: Hypertension with insulin resistance, dyslipidemia, impaired fasting glucose 2. Valsartan capsules 80 mg 1 / d rosiglitazone maleate tablets 4 mg 1 / d 3. Analysis (1) obesity, body fat distribution And hypertension According to clinical and epidemiological studies, obesity is often assessed by body mass index (BMI, body weight (kg) / height (m) 2), as defined by the World Health Organization: BMI ≥25 kg / m2 is overweight, BMI ≥30